Plants and parts of plants used in food supplements: An approach to their safety assessment

Annali dell'Istituto Superiore di Sanita

Volumn 46, Issue 4, 2010, Pages 370-388

  Carratù, Brunella ^a   Federici, Elena ^a   Gallo, Francesca R ^a   Geraci, Andrea ^a   Guidotti, Marco ^a   Multari, Giuseppina ^a   Palazzino, Giovanna ^a   Sanzini, Elisabetta ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Botanicals; Food supplements; Herbal products; Safety assessment

Indexed keywords

PLANT MEDICINAL PRODUCT;

ARTICLE; DIET SUPPLEMENTATION; HUMAN; ITALY; MEDICINAL PLANT; MEDICOLEGAL ASPECT; SAFETY;

DIETARY SUPPLEMENTS; HUMANS; ITALY; LEGISLATION, MEDICAL; PLANT PREPARATIONS; PLANTS, MEDICINAL; SAFETY;

EID: 79551575432     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.4415/Ann-10-04-05     Document Type: Article

References (253)

1. European Union. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the member States relating to food supplements. Official Journal of the European Communities L 183/51, 12 July 2002.
2. European Union. Directive 2004/24/EC of the European Parliament and of the Council of 31 march 2004 amending as regards herbal medicinal products Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Communities L 136/85, 30 April 2004.
3. Italia. Decreto legislativo 21 maggio 2004 n. 169. Attuazione della direttiva 2002/46/CE relativa agli integratori alimentari. Gazzetta Ufficiale - Serie Generale n. 164, 15 luglio 2004.
4. EFSA Scientific Cooperation (ESCO), Working Group on Botanicals. Draft compendium of botanicals that have been considered for a food and/or a food supplement use and that have been reported to contain toxic or addictive or psychotropic substances. June 2008.
5. EFSA Scientific Cooperation (ESCO), Working Group on Botanicals. Draft compendium of botanicals and botanical preparations that have been considered for food and/or food supplement use and have been reported to have also a medicinal use. June 2008.
6. Hoppe HA. Drogen Kunde. Berlin-New York: Walter de Gruyter; 1975.
7. Hegnauer R. Chemotaxonomie der Pflanzen. Basel-Boston-Berlin: Birkhäuser Verlag; 1992 and 2001.
8. India, ministry of Health and Family Welfare, Department of Indian Systems of medicine & Homoeopathy. The ayurvedic pharmacopoeia of India.. New Delhi: National Institute of Science Communication (CSIr); 2001.
9. Zhou J, Xie G, Yan X. Traditional Chinese medicines, molecular structures, natural sources and application. Hampshire-Burlington: Ashgate Publishing Lmtd, GWA Milne Editor; 2003.
10. Duke JA. Handbook of medicinal herbs. Boca Raton: CRC Press; 2000.
11. Kapoor LD. Handbook of ayurvedic medicinal plants. Boca Raton: CRC Press; 2000.
12. Gruenwald J, Brendeler T, Jaenicke C, Fileming T (Ed.). Physicians' desk reference (PDR) for herbal medicines. 2. Ed. Montvale-w Jersey: Medical Economics Company; 2000.
13. Ministero della Salute. Alimenti particolari e integratori. Integratori alimentari. Available from: www.salute.gov. it.
14. European Medicines Agency Regulatory. Human medicines. Herbal products. Available from: www.ema.europa.eu.
15. European Food Safety Authority. Scientific documents. Botanicals. Available from: www.efsa.europa.eu.
16. Council of Europe, Committee of Experts on Flavouring Substances - Active principles (constituents of toxicological concern) contained in natural sources of flavourings. Health Protection of the Consumer Series, Strasbourg: Council of Europe Press; October 2005. Available from: www.coe.int/t/e/social-cohesion/ soc-sp/public-health/flavouring-substances/Active%20principles.pdf.
17. Council of Europe, Committee of Experts on Flavouring Substances. Natural sources of flavourings. Report No. 3. Belgium: Council of Europe Publishing; 2008.
18. European Food Safety Authority. Opinion of the Scientific Panel on food additives, flavourings, processing aids and material in contact with food (AFC) on a request from the Commission related to coumarin. Question number EFSA-Q-2003-118. The EFSA Journal 2004;104:1-36.
19. Bruni A, Nicoletti M. Dizionario ragionato di erboristeria e di fitoterapia. Padova: Piccin; 2003. p. 523
20. Bruni A, Nicoletti M. Lezioni di botanica farmaceutica. Roma: CISU; 2000.
21. Stewart MJ, Steenkamp V. Pyrrolizidine poisoning: a neglected area in human toxicology. Ther Drug Monit 2001;23:698-708.
22. EFSA Scientific Cooperation (ESCO). Compendium of botanicals that have reported to contain toxic or addictive or psychotropic substances. The EFSA Journal 2009;7:281-79.
23. Swenberg JA. Covalent binding index study on coumarin. In: Report of laboratory of molecular carcinogenesis and mutagenesis. University of North Carolina, Chapel Hull, NC, USA and by European Flavour and Flagrance Association (EFFA): Brussels; 2003.
24. European Medicines Agency, Committee on Herbal Medicinal Products. Public statement on the use of herbal medicinal products containing estragole. London, 23 November 2005. Doc. Ref: EMEA/HmPC/137212/2005.
25. Joint FAO/WHO Expert Committee on Food Additives (JECFA). Eugenol and related hydroxyallylbenzene derivatives In: Safety evaluation of certain food additives. Geneva: WHO; 2005. p. 155-200. (WHO Food Additives Series n. 56).
26. th meeting) structurally related to ring-substituted phenolic substances evaluated by EFSA in FGE.22 (2006). Question number EFSA-2008-32L. The EFSA Journal 2009;965:1-53.
27. European Commission, Scientific Committee on Food. Opinion of the Scientific Committee on Food on glycyrrhizinic acid and its ammonium salt. 4 April 2003. Available from: http://ec.europa.eu/food/fs/sc/scf/out186-en.pdf.
28. Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of glycyrrhizic acid. Int J Toxicol 2007;26(Suppl. 2):79-112.
29. European Food Safety Authority. Opinion of the Scientific Panel on contaminants. Ethyl carbamate and hydrocyanic acid in food and beverages. Question number EFSA-Q-2006-076 The EFSA Journal 2007;551:1-44.
30. Italia. Decreto Legislativo 25 gennaio1992 n. 107. Attuazione delle direttive 88/388/CEE e 91/71/CE relative agli aromi destinati ad essere impiegati nei prodotti alimentari ed ai materiali di base per la loro preparazione. Gazzetta Ufficiale - Supplemento Ordinario n. 39, 17 febbraio 1992.
31. European Union. Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods and amending Council regulation (EEC) No 1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. Official Journal of the European Union 2008; L354:34-48.
32. European Medicines Agency, Committee on Herbal Medicinal Products. Public statement on the use of herbal medicinal products containing pulegone and menthofuran. London, 23 November 2005. Doc Ref: EMEA/HMPC/138386/2005.
33. Thorup I, Würtzen G, Carstensen J, Olsen P. Short term toxicity study in rats dosed with peppermint oil. Toxicol Lett 1983;19(3):211-5. (Pubitemid 14208517)
34. European Food Safety Authority. Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with foods on a request from the Commission on pulegone and menthofuran in flavourings and other food ingredients with flavouring properties. Question number EFSA-Q-2003-119. Adopted on 7 December 2005. The EFSA Journal 2005;298:1-32.
35. Nair B. Final report on the safety assessment of mentha Piperita (Peppermint) Oil, mentha Piperita (Peppermint) Leaf Extract, mentha Piperita (Peppermint) Leaf, and mentha Piperita (Peppermint) Leaf Water. Int J Toxicol 2001;20(Suppl. 3):61-73.
36. Organization for Economic Cooperation and Development. Menthols. Paris: UNEP Publications; 2003. p. 14.
37. Joint FAO/WHO Expert Committee on Food Additives (JECFA). Menthol In: Safety evaluation of certain food additives. Geneva: WHO; 1999. (WHO Food Additives Series n. 42).
38. National Toxicology Program. Toxicology and carcinogenesis studies of methyleugenol (CAS No. 93-15-2) in F344/N rats and B6C3F1 mice (gavage studies). Research Triangle Park, NC: US Department of Health and Human Service; 2000. (NTP TR 491, NIH Publication n. 00-3950).
39. National Toxicology Program. Toxicology and carcinogenesis studies of methyleugenol (CAS No. 93-15-12). In F344/N rats and B6C3F1 mice (gavage studies). Research Triangle Park, NC: US Department of Health and Human Service: 1998. (NTP TR 491, NIH Publication n. 98-3950).
40. European Commission, Scientific Committee on Food. Opinion of the Scientific Committee on Food on Methyleugenol (1, 4-Allyl-1, 2-dimethoxybenzene). 2001. Doc Ref: SCF/CS/FLAV/FLAVOUr/4 ADD1 FINAL-26 September 2001.
41. th JECFA. Available from: ftp://ftp.fao.org/es/esn/jecfa/cta-65- quillaia.pdf.
42. Joint FAO/WHO Expert Committee on Food Additives (JECFA). Quillaia extracts. In: Safety evaluation of certain food additives. Geneva: WHO; 2002. (WHO Food Additives Series n. 48). Avalaible from: www.inchem.org/documents/ jecfa/jecmono/v48je03.htm.
43. Joint FAO/WHO Expert Committee on Food Additives (JECFA). Quillaia Extracts. In: Evaluation of certain food additives. Geneva: WHO; 2006. (WHO Technical Report Series No 934). p. 28-33.
44. Federal Institute for Risk Assessment (BfR). Quinine-containing beverages may cause health problems. Update BfR Health Assessment n. 020; 2005. Available from: www.bfr.bund.de/cm/245/quinine-containing-beverages-may-cause-health- problems.pdf.
45. European Food Safety Authority. Opinion of the Scientific Panel on food additives, flavourings, processing aids and material in contact with food. Three quinine salts from the priority list from chemical group 30. Question number EFSA-Q-2003-172B. The EFSA Journal 2008;739:1-18.
46. International Agency for Research on Cancer (IARC). Some naturally occurring substances. Lyon, France: IARC; 1976. (IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. 10). 353 p.
47. European Commission, Scientific Committee on Food. Opinion of the Scientific Committee on Food on the safety of the presence of safrole (1-allyl-3, 4-methylene dioxy benzene) in flavourings and other food ingredients with flavouring properties. 12 December 2001. Available from: http://ec.europa. eu/food/fs/sc/scf/out116-en.pdf.
48. Wislocki PG, Borchest P, Miller JA, Miller EC. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilicreactivities of possible ultimate carcinogens. Cancer Res 1976;36:1686-95.
49. Jenner PM, Hagan EC, Taylor JM, Cook EL, Fitzhugh OG. Food flavourings and compounds of related structure. I. Acute oral toxicity. Food Cosm Toxicol 1964;2:327-43.
50. Daimon H, Sawada S, Asakura S, Sagani F. In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole. Carcinogenesis 1998;19:141-6.
51. Meschler JP, Howlett AC. Thujone exhibits low affnity for cannabinoid receptors but fails to evoke cannabimimetic responses. Pharmacol Biochem Behav 1999;62:473-80.
52. Hold KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE. Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proc Natl Acad Sci USA 2000;97(8):3826-31.
53. Burkhard PR, Brukhardt K, Haenggeli CA, Landis T. Plantinduced seizures: reappearance of an old problem. J Neurol 1999;246:667-70.
54. Strang J, Arnold WN, Peters T. Absinthe: what's your poison? Brit Med J 1999;319:1590-1.
55. European Commission, Scientific Committee on Food. Opinion of the Scientific Committee on Food on Thujone (expressed on 2 December 2002). Doc Ref: SCF/CS/FLAV/FLAVOUR/23 ADD2 Final.
56. Margaria R. Acute and sub-acute toxicity study on thujone. Unpublished report of the Istituto di Fisiologia, Universita di Milano 1963 (cited from CoE Datasheet RD4.2/14-44, 1999).
57. Toxnet. Anethole. Hazardous Substances Data Bank. Avalaible from: http://toxnet.nlm.nih.gov.
58. Oka Y, Nacar S, Putievsky E, Ravid U, Yaniv Z, Spiegel Y. Nematicidal activity of essential oils and their components against the root-knot nematode. Phytopathology 2000;90(7):710-5.
59. Yea SS, Jeong HS, Choi CY, Park KR, Oh S, Shin JG, Yun CH. Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1. Toxicol in vitro 2006;20(7):1098-105.
60. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001;16:115-7.
61. Assimopoulou AN, Papageorgiou VP. Radical scavenging activity of Alkanna tinctoria root extracts and their main constituents, hydroxynaphthoquinones. Phytother Res 2005;19:141-7.
62. Broadbent JL, Schnieden H. A comparison of some pharmacological properties of dioscorine and dioscine. Brit J Pharmacol 1958;13:213.
63. Sauvaire Y, Baccou JC. Extraction of diosgenine, (25R) - spirost-5-ene-3beta-ol; problems of the acid hydrolysis of the saponins. Lloydia 1978;41:247-56.
64. Hooker E. Final report of the amended safety assessment of Dioscorea villosa (Wild Yam) root extract. Int J Toxicol 2004;23:49-54.
65. Stermitz FR, Schneider MJ, Schell LD, McGregor S, James LF, et al. (Ed.). Toxic international symposium. Utah, USA: Logan; 1988. p. 204-7.
66. Schafer HL, Schafer H, Schneider W, Elstner EF. Sedative action of extract combinations of Eschscholtzia californica and Corydalis cava. Arzneim Forsch 1995;45(2):124-6.
67. Fabre N, Claparols C, Richelme S, Angelin ML, Fouraste I, Moulis C. Direct characterization of isoquinoline alkaloids in a crude plant extract by ion-pair liquid chromatography-electrospray ionization tandem mass spectrometry: example of Eschscholtzia californica. J Chromatogr A 2000;904(1):35-6.
68. Paul LD, Maurer HH. Studies on the metabolism and toxicological detection of the Eschscholtzia californica alkaloids californine and protopine in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003;789(1):43-57.
69. Singh S, Jain L, Pandey MB, Singh UP, Pandey VB. Antifungal activity of the alkaloids from Eschscholtzia californica. Folia Microbiol (Praha) 2009;54(3):204-6.
70. Grag SK, Saksena SK, Chaudhury RR. Antifertility screening of plants. VI. Effect of five indigenous plants on early pregnancy in albino rats. Indian J Med Res 1970;58:1285-9.
71. Lee H, Lin JY. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine. Mutat Res 1988;204:229-34.
72. Hong CY, Huang JJ, Wu P. The inhibitory effect of gossypol on human sperm motility: relationship with time, temperature and concentration. Human toxicol 1989;8:49-51.
73. Budavari S (Ed.). Cottonseed oil. The Merk Index. Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc.; 1989.
74. Edenharder R, von Petersdorff I, Rauscher R. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food. Mutat Res 1993;287:261-74.
75. Coutinho EM, Athayde C, Atta G, Gu ZP, Chen ZW, Sang GW, Emuveyan E, Adekunle AO, Mati J, Otubu J, Reidenberg MM, Segal SJ. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study. Contraception 2000;61:61-7.
76. Mondini C, Dell'Abate MT, Leita L, Benedetti A. An integrated chemical, thermal, and microbiological approach to compost stability evaluation. J Environ Qual 2003;32:2379-86.
77. Lordelo MM, Davis AJ, Calhoun MC, Dowd MK, Dale NM. Relative toxicity of gossypol enantiomers in broilers. Poult Sci 2005;84:1376-82.
78. Bezemer TM, Wagenaar R, van Dam NM, van der Putten WH, Wäckers FL. Above-and below-ground terpenoid aldehyde induction in cotton, Gossypium herbaceum, following root and leaf injury. J Chem Ecol 2004;30:53-67.
79. Stipanovic RD, Puckhaber LS, Bell AA, Percival AE, Jacobs J. Occurrence of (+) - and (-)-gossypol in wild species of cotton and in Gossypium hirsutum var. marie-galante (Watt) Hutchinson. J Agric Food Chem 2005;53:6266-71.
80. Indovina P, Rainaldi G, Santini MT. Three-dimensional cell organization leads to a different type of ionizing radiationinduced cell death: MG-63 monolayer cells undergo mitotic catastrophe while spheroids die of apoptosis. Int J Oncol 2007;31:1473-83.
81. Indovina P, Rainaldi G, Santini MT. Hypoxia increases adhesion and spreading of MG-63 three-dimensional tumor spheroids. Anticancer Res 2008;28:1013-22.
82. Amara AA, El-Masry MH, Bogdady HH. Plant crude extracts could be the solution: extracts showing in vivo antitumorigenic activity. Pak J Pharm Sci 2008;21:159-71.
83. Menegassi A, Wassermann GE, Olivera-Severo D, Becker-Ritt AB, Martinelli A H S, Feder V, Carlini CR. Urease from cotton (Gossypium hirsutum) seeds: isolation, physicochemical characterization, and antifungal properties of the protein. J Agric Food Chem 2008;56:4399-405.
84. Przybylski P, Pospieszny T, Huczyński A, Brzezinski B. EI MS and ESI MS studies of the bisesquiterpene from cotton seeds: gossypol and its aza-derivatives. J Mass Spectrom 2008;43(5):680-6.
85. Saad B, Dakwar S, Said O, Abu-Hijleh G, Al Battah F, Kmeel A, Aziazeh H. Evaluation of medicinal plant hepatotoxicity in co-cultures of hepatocytes and monocytes. Evid Based Complement Altern Med 2006;3:93-8.
86. Food and Drug Administration, Centre for Food Safety and Applied Nutrition. Perilla frutescens. FDA Poison Plant Database. FDA; 2006.
87. Floss HG, Mothes U. On the biosynthesis of furocoumarins in Pimpinella magna. Phytochemistry 1966;5(1):161-9.
88. Wessely F, Neugebauer L. Contents of the root of Pimpinella saxifraga. Monatsch Chem 1953;84:217.
89. Kubwabo C, Rollmann B, Tilquin B. Analysis of Alkaloids from Physalis peruviana by capillary GC, capillary GC-MS and GC-FTIR. Planta Med 1993;59(2):161-3.
90. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996;38:280-2.
91. Mazzanti G, Battinelli L, Daniele C, Mastroianni CM, Lichtner M, Coletta S, Costantini S. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Annals Intern Med 2004;140: W30. Available from www.annals.org/cgi/content/full/140/7/ W-30.
92. Panis B, Wong DR, Hooymans PM, De Smet PA, Rosias PP. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005;41:256-8.
93. Germany. Bundesinstitut für Arzeneimittel und Medizinprodukte. Kommission E. Ruta graveolens (Raute) Monograph. Bundesanzeiger 1989. N. 43 on 02/03/1989.
94. Newall CA, Anderson LA, Phillipson JD (Ed.). Herbal medicines. A guide for health-care professionals. London: The Pharmaceutical Press; 1996.
95. Hutson D, Cupp MJ. Sassafras. In: Cupp MJ (Ed). Toxicology and clinical pharmacology of herbal products. Totowa, New Jersey: Humana Press Inc; 2000. p. 245-52.
96. Fontaine J, Elchami AA, Vanhaelen M, Vanhaelen-Fastre R. Biological analysis of Harpagophytum procumbens D. C. Part 2. Pharmacological analysis of the effects of harpagoside, harpagide and harpagogenin on the isolated guinea pig ileum. J Pharm Belg 1981;36:321-4.
97. Breschi MC, Martinotti E, Catalano S, Flamini G, Morelli I, Pagni AM. Vasoconstrictor activity of 8-0-acetylharpagide from Ajuga reptans. J Nat Prod 1992;55:1145-8.
98. Bartholomaeus A, Ahokas J. Inhibition of P-450 by aucubin: is the biological activity of aucubin due to its glutaraldehyde-like aglycone? Toxicol Lett 1995;80:75-83.
99. Miyase T, Yamamoto R, Ufno A. Phenylethanoid glycosides from Stachys officinalis. Phytochemistry 1996;43:475-9.
100. Kim DH, Kim BR, Kim JY, Jeong YC. Mechanism of covalent adduct formation of aucubin to proteins. Toxicol Lett 2000;114(1-3): 181-8.
101. Vundac VB, Pfeifhofer HW, Brantner AH, Males Z, Plazibat M. Essential oils of seven Stachys taxa from Croatia. Biochem Syst Ecol 2006;34(12):875-81.
102. Akkol EK, Tatli II, Akdemir ZS. Antinociceptive and anti-inflammatory effects of saponin and iridoid glycosides from Verbascum pterocalycinum var. mutense Hub. Mor. Z Naturforsc 2007;62(11-12): 813-20.
103. Háznagy-Radnai E, Réthy B, Czigle Sz, Zupkó I, Wéber E, Martinek T, Falkay G, Máthé I. Cytotoxic activities of Stachys species. Fitoterapia 2008;79(7-8): 595-7.
104. Pagnoni UM, Pinetti A, Trave R, Garanti L. Monoterpenes of Teucrium marum. Aust J Chem 1976;29(6):1375-81.
105. Sanz J, Mus M, Rossello JA. Volatile components variation in the Teucrium marum complex (Lamiaceae) from the Balearic Island. Bot J Linn Soc 2000;132(3):253-61.
106. Eisner T, Eisner M, Anashansley DJ, Wu CL, Meinwalt J. Chemical defense of the mint plant. Teucrium marum (Labiatae). Chemoecology 2000;10(4):211-6.
107. Ricci D, Fraternale D, Giamperi L, Bucchini A, Epifano F, Burini G, Curini M. Chemical composition, antimicrobial and atioxidant activity of the essential oil of Teucrium marum (Lamiaceae). J Ethnopharmacol 2005;98(1-2): 195-200.
108. Brown-Woodman P D C, Mohri H, Mohri T, Suter D, White IG. Mode of action of alpha-chlorohydrin as a male antifertility agent. Inhibition of the metabolism of ram spermatozoa by alpha-chlorohydrin and location of block in glycolysis. Biochem J 1978;170(1):23-37.
109. Malakov PY, Papanov GY, Boneva IM. Neo-clerodane diterpenoids from Teucrium montanum. Phytochemistry 1992;31(11):4029-30.
110. Rodriguez B. Oxirane-opening reactions of some 6, 19-oxygenated 4-α, 18-epoxy-neo-clerodanes isolated from Teucrium. Biogenesis and antifeedant activity of their derivatives. Tetrahedron 1994;50(18):5451-68.
111. Kisiel W, Piozzi F, Grzybek J. Terpenoids from Teucrium montanum subsp. pannonicum. Planta Med 1995;61(2):191-2.
112. Chen I-C, Wu Y-K, Liu H-J, and Zhu J-L. Total syntheses of (±)-montanin A and (±)-teuscorolide. Chem Commun 2008;4720-2.
113. Lekehal M, Pessayre D, Lereau JM, Moulis C, Fouraste I, Fau D. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996;24(1):212-8.
114. De Berardinis V, Moulis C, Maurice M, Beaune P, Pessayre D, Pompon D, Loeper J. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000;58(3):542-51.
115. Starakis I, Siagris D, Leonidou L, Mazokopakis E, Tsamandas A, Karatza C. Hepatitis caused by the herbal remedy Teucrium polium L. Eur J Gastroenterol Hepatol 2006;18(6):681-3.
116. Savvidou S, Goulis J, Giavazis I, Patsiaoura K, Hytiroglou P, Arvanitakis C. Herb-induced hepatitis by Teucrium polium L.: report of two cases and review of the literature. Eur J Gastroenterol Hepatol 2007;19(6):507-11.
117. Jakupovic J, Baruah RN, Bohlmann F, Quack W. New Clerodane Derivatives from Teucrium scordium L. Planta Med 1985;51(4):341-2.
118. Grieve M. A modern herbal. London: Penguin Books, Leyel CF; 1984.
119. Altmann H. Poisonous plants and animals. London: Chatto and Windus; 1980.
120. Chevallier A. Encyclopedia of medicinal plants. London: Dorling Kindersley; 1996.
121. Bown D. Encyclopaedia of herbs and their uses. London: Dorling Kindersley; 1995.
122. Chiej R. Encyclopaedia of medicinal plants. Edinburgh: MacDonald; 1984.
123. Stary F. Poisonous plants. UK: Hamlyn; 1983.
124. Lust J. The herb book. USA: Bantam books; 1983.
125. Uphof JC. Dictionary of economic plants. Weinheim, Germany: HR Engelman; 1959.
126. Freethy R. From agar to zenery. Marlborough, United Kingdom: The Crowood Press; 1985.
127. Mills SY. The dictionary of modern herbalism: A comprehensive guide to practical herbal therapy. Wellingborough, New York: Thorsons Pub Group; 1985.
128. World Health Organisation. Medicinal plants in the Republic of Korea n. 21. Manila: WHO; 1998.
129. Morita H, Sato Y, Chan KL, Choo CY, Itokawa H, Takeya K, Kobayashi J, Samoquasine A. Benzoquinoline alkaloid from the seeds of Annona squamosa J Nat Prod 2000;63(12):1707-8.
130. Chang FR, Liaw CC, Lin CY, Chou CJ, Chiu HF, Wu YC. New adjacent bis-tetrahydrofuran Annonaceous acetogenins from Annona muricata. Planta Med 2003;69(3):241-6.
131. Lannuzel A, Michel PP, Hoeglinger GU, Champy P, Jousset A, Medja F. The mitochondraial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Neuroscience 2003;121(2):287-96.
132. Ahmad KF, Sultana N. Biological studies on fruit pulp and seeds of Annona squamosa. J Chem Soc Pak 2003;25(4):331-3.
133. Rahman MM, Parvin S, Haque ME, Islam ME, Mosaddik MA. Antimicrobial and cytotoxic constituents from the seeds of Annona squamosa. Fitoterapia 2005;76(5):484-9.
134. Champy P, Melot A, Guérineau Eng V, Gleye C, Fall D, Höglinger GU, Ruberg M, Lannuzel A, Laprévote O, Laurens A, Hocquemiller R. Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in Guadeloupe. Mov Disord 2005;20(12):1629-33.
135. Lannuzel A, Hoglinger GU, Champy P, Michel PP, Hirsch EC, Ruberg M. Is a atypical parkinsonism in the Caribbean caused by the consumption of Annonacae? J Neural Transm Suppl 2006;70:153-7.
136. Mohanty S, Hollinshead J, Jones L, Jones PW, Thomas D, Watson AA, Watson DG, Gray AI, Molyneux RJ, Nash RJ. Annona muricata. Toxic or therapeutic. Nat Prod Commun 2008;3(1):31-3.
137. Derevinskaya TI, Pakaln DA. Some problems of the quality of drug-technical raw material of Asimina triloba. Farm Zh 1983;38:49-52.
138. Zhao G, Hui Y, Rupprecht JK, McLaughlin JL, Wood KV. Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba. J Nat Prod 1992;55(3):347.
139. He K, Shi G, Zhao GX, Zeng L, Ye Q, Schwedler JT, Wood KV, McLaughlin JL. Three new adjacent bis-tetrahydrofuran acetogenins with four hydroxyl groups from Asimina triloba. J Nat Prod 1996;59:1029-34.
140. Zhao GX, Chao JF, Zeng L, Rieser MJ, McLaughlin JL. The absolute configuration of adjacent bis-THF acetogenins and asiminocin, a novel highly potent asimicin isomer from Asimina triloba. Bioorg Med Chem 1996;4(1):25-32.
141. Woo MH, Kim DH, McLaughlin JL. Asitrilobins A and B: Cytotoxic mono-THF Annonaceous acetogenins from the seeds of Asimina triloba. Phytochemistry 1999;50(6):1033-40.
142. Pharmacopoeia of the People's Republic of China, 232, 1043. Hong Kong: Lie Young & Young Creation; 1988.
143. Kout O, Isman MB. Toxicity of the limonoid allelochemical cedrelone to noctuid larvae. Entomol Exp Appl 1992;64(3):281-7.
144. Wali U, Rehman R. Trial of insecticides and a fumigant against forest seed pests. Pakistan J Forest 1993;43(2):85-90.
145. Malairajan P, Gopalakrishnan G, Narasimhan S, Veni KJ, Kavimani S. Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood). J Ethnopharmacol 2007;110(2):348-51.
146. Ogan AU. The alkaloids in the leaves of Combretum micranthum. Studies on West African medicinal plants. VII. Planta Med 1972;21:210-7.
147. Bassene E, Olschwang D, Pousset JL. African medicinal plants: alkaloids of Combretum micranthum G. Don (Kinkeliba). Ann Pharm Fr 1986;44(3):191-6. (Pubitemid 17170494)
148. Ferrea G, Canessa A, Sampietro F, Cruciani M, Romussi G, Bassetti D. In vitro activity of a Combretum micranthum extract against Herpes simplex virus types 1 and 2. Antiviral Res 1993;21(4):317-25.
149. Ancolio C, Azas N, Mahiou V, Ollivier E, Di Giorgio C, Keita A, Timon-David P, Balansard G. Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytother Res 2002;16(7):646-9.
150. Benoit F, Valentin A, Pellissier Y, Diafouka E, Marion C, Kone-Bamba D, Kone M, Mallie M, Yapo A, Bastide JM. In vitro antimalarial activity of vegetal extracts used in West African traditional medicine. Am J Trop Med Hyg 1996;54(1):67-71.
151. Karou D, Dicko MH, Sanon S, Simpore J, Traore AS. Antimalarial activity of Sida acuta Burm. f. (Malvaceae) and Pterocarpus erinaceus Poir. (Fabaceae). J Ethnopharmacol 2003;89(2-3): 291-4.
152. Olajide OA, Makinde JM, Okpako DT. Evaluation of the anti-inflammatory property of the extract of Combretum micranthum G. Don (Combretaceae). Inflammopharmacology 2003;11(3):293-8.
153. Küster E. Cholin-and carboxylesterase activities in developing zebrafish embryos (Danio rerio) and their potential use for insecticide hazard assessment. Aquatic Toxicol 2005;75(1):76-85.
154. Ohsaki A, Yan LT, Ito S, Edatsugi H, Iwata D, Komoda Y. The isolation and in vivo potent antitumor activity of clerodane diterpenoids from the oleoresin of Brazilian medicinal plant Copaifera langsdorfii Desfon. Bioorg Med Chem Lett 1994;4:2889-92.
155. Paiva L A F, Rao V S N, Gramosa NV, Silveira ER. Gastroprotective effect of Copifera langsdorffii oleo-resin on experimental gastric ulcer models in rats. J Ethnopharmacol 1998;62(1):73-8.
156. Gomes NM. Antinociceptive activity of Amazonian Copaiba oils. J Ethnopharmacol 2007;109(3):486-92.
157. Cascon V, Gilbert B. Characterization of the chemical composition of oleoresins of Copaifera guianensis Desf, Copaifera duckei Dwyer and Copaifera multijuna Hayne. Phytochemistry 2000;55(7):773-8.
158. Paiva LA, Gurgel LA, Silva RM, Tomé AR, Gramosa NV, Silveira ER, Santos FA, Rao VS. Anti-inflammatory effect of kaurenoic acid, a diterpene from Copaifera langsdorffi on acetic acid-induced colitis in rats. Vascular Pharmacol 2002;39(6):303-7.
159. Costa-Lotufo LV, Cunha G M A, Farias P A M, Viana G S B, Cunha K M A, Pessoa C, Moraes MO, Silveira ER, Gramosa NV, Rao V S N. The cytotoxic and embryotoxic effects of kaurenoic acid, a diterpene isolated from Copaifera langsdorffi Toxicon 2002;40(8):1231-4.
160. Krauchenco S, Nagem R A P, Da Silva JA, Marangoni S, Polikarpov I. Three-dimensional structure of an unusual Kunitz (STI) type trypsin inhibitor from Copaifera langsdorffi Biochimie 2004;86(3):167-72.
161. Namba T, Mikage M, Ushiyama T. Fundamental studies on the evaluation of crude drugs. Part 6. Electron microscopic analysis of crude drugs. Part 1. Determination of berberine in Coptidis Rhizoma. J Pharm Soc Jap 1982;102:56-62.
162. Mizuno M, Kojima H, Tanaka T, Iinuma M, Min Z, Murata H. Benzophenanthridine alkaloids from the seeds of Coptis japonica var. dissecta. J Nat Prod 1987;50:326.
163. Lee MK, Kim HS. Inhibitory effects of protoberberine alkaloids from the roots of Coptis japonica on catecholamine biosynthesis in PC12 cells. Planta Med 1996;62(1):31-4.
164. Park H, Kim MS, Jeon BH, Kim TK, Kim YM, Ahnn J, Kwon DY, Takaya Y, Wataya Y, Kim HS. Antimalarial activity of herbal extracts used in traditional medicine in Korea. Biol Pharm Bull 2003;26(11):1623-4.
165. Erdelmeier C A, Sticher O. Coumarin derivatives from Eryngium campestre. Planta Med 1985;51(5):407-9.
166. García MD, Sáenz MT, Gómez MA, Fernández MA. Topical antiinflammatory activity of phytosterols isolated from Eryngium foetidum on chronic and acute inflammation models. Phytother Res 1999;13(1):78-80.
167. Kartal M, Mitaine-Offer AC, Abu-Asaker M, Miyamoto T, Calisi I, Wagner H, Lacaille-Dubois MA. Two new triterpene saponins from Eryngium campestre. Chem Pharm Bull 2005;53(10):1318-20.
168. Kupeli E, Kartal M, Asian S, Yesilada E. Comparative evaluation of the anti-inflammatory and antinociceptive activity of Turkish Eryngium species. J Ethnopharmacol 2006;107(1):32-7. (Pubitemid 44056298)
169. Hegnauer R. Chemotaxonomie der Pflanzen. Basel-Boston-Berlin: Birkhäuser Verlag; 1990.
170. Kartal M, Mitaine-Offer AC, Paululat T, Abu-Asaker M, Wagner H, Mirjolet JF, Guilbaud N, Lacaille-Dubois MA. Triterpene saponins from Eryngium campestre. J Nat Prod 2006;69(7):1105-8.
171. Dahlquist I, Fregert S. Contact allergy to atranorin in lichens and perfumes. Contact Dermatitis 1980;6(2):111-9.
172. Loppi S, Pacioni G, Olivieri N, Di Giacomo F. Accumulation of trace metals in the lichen Everina prunastri transplanted at biomonitoring sites in central Italy. Bryologist 1998;101(3):451-4.
173. Breckle SW, Kahle H. Effects of toxic heavy metals (cadmium, lead) on growth and mineral nutrition of beech (Fagus sylvaticah.). Vegetatio 1992;101(1):43-53.
174. Nassar MI. Spectral study of farnesiferol B from Ferula assa foetida L. Pharmazie 1994;49:542-3.
175. Saleem M, Alam A, Sultana S. Asafoetida inhibits early events of carcinogenesis A chemopreventive study. Life Sci 2001;68(16):1913-21.
176. Mohamed H, El-Razek A, Ohtab S, Ahmedc AA, Hirataa T. Monoterpene coumarins from Ferula ferulago. Phytochemistry 2001;57(8):1201-3.
177. Mallikarjuna GU, Dhanalakshmi S, Raisuddin S, Rao AR. Chemomodulatory influence of Ferula asafoetida on mammary epithelial differentiation, hepatic drug metabolizing enzymes, antioxidant profiles and N-Methyl-N- Nitrosoureainduced mammary carcinogenesis in rats. Breast Cancer Res Treat 2003;81:1-10.
178. Zhou J, Xie G, Yan X. Traditional Chinese medicines, molecular structures, natural sources and application. Hampshire-Burlington: AshgatePublishing Lmtd, GWA Milne Editor; 2003.
179. Rasulev BF, Saidkhodzhaev AI, Nazrullaev SS, Akhmedkhodzhaeva KS, Khushbaktova ZA, Leszczynski J. Molecular modelling and QSAR analysis of the estrogenic activity of terpenoids isolated from Ferula plants. SAR QSAR Environ Res 2007;18(7-8): 663-73.
180. Shahverdi AR, Fakhimi A, Zarrini G, Dehghan G, Iranshahi M. Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biol Pharm Bull 2007;30(9):1805-7.
181. Monti M, Pinotti M, Appendino G, Dallocchio F, Bellini T, Antognoni F, Poli F, Bernardi F. Characterization of anti-coagulant properties of prenylated coumarin ferulenol. Biochim Biophys Acta 2007;1770(10):1437-40.
182. Ojala T, Vuorela P, Kiviranta J, Vuorela H, Hiltunen R. A bioassay using Artemia salina for detecting phototoxicity of plant coumarins. Planta Med 1999;65(8):715-8.
183. Yarnell E. Botanical medicines for the urinary tract. World J Urol 2002;20(5):285-93.
184. Vollekova A, Kostalova D, Kettmann V, Toth J. Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids. Phytother Res 2003;17(7):834-7.
185. El Sattar SA, El Batran, El Gengaihi SE, El Shabrawya OA. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol 2006;108:236-42.
186. Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Br J Nutr 2009;13(1):1-6.
187. Hayes LW, Krasselt WG, Mueggler PA. Concentrations of morphine and codeine in serum and urine after ingestion of poppy seeds. Clin Chem 1987;33(6):806-8.
188. Pettitt BC Jr, Dyazel SM, Hood L V S. Opiates in poppy seed: effect on urinalysis results after consumption of poppy seed cake-filling. Clin Chem 1987;33(7):1251-2.
189. ElSohly HN, ElSohly MA, Stanford DF. Poppy seed ingestion and opiates urinalysis: a closer look. J Anal Toxicol 1990;14(5):308-10.
190. Selavka CM. Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: the Pacific perspective. J Forensic Sci 1991;36(3):685-96.
191. Unnithan S, Strang J. Poppy tea dependence. Br J Psychiatry 1993;163:813-4.
192. Meadway C, George S, Braithwaite R. Opiate concentrations following the ingestion of poppy seed products - evidence for "the poppy seed defence". Forensic Sci Int 1998;96(1):29-38.
193. Soulimani R, Younos C, Jarmouni-Idrissi S, Bousta D, Khallouki F, Laila A. Behavioral and pharmaco-toxicological study of Papaver rhoeas L. in mice. J Ethnopharmacol 2001;74(3):265-74.
194. Braye K, Harwood T, Inder R, Beasley R, Robinson G. Poppy seed tea and opiate abuse in New Zealand. Drug Alcohol Rev 2007;26(2):215-9.
195. Chen SJ, Wu BN, Yeh JL, Lo YC, Chen IS, Chen IJ. C-fiber-evoked autonomic cardiovascular effects after injection of Piper betle inflorescence extract. J Ethnopharmacol 1995;45(3):183-8.
196. Chen CL, Chi CW, Chang KW, Liu TY. Safrole-like DNA adducts in oral tissue from oral cancer patients with betel quid chewing history. Carcinogenesis 1999;20(12):2331-4.
197. Chu NS. Effects of Betel chewing on the central and autonomic nervous systems. J Biomed Sci 2001;8(3):229-36.
198. Guha P. Betel leaf: the neglected green gold of India. J Hum Ecol 2006;19(2):87-93.
199. Germany. Bundesinstitut für Arzeneimittel und Medizinprodukte. Kommission E. Pthychopetali lignum (Potenzholz) Monograph. Bundesanzeiger 1987. N. 193 on 15.10.1987.
200. Hegnauer R. Ptychopetalum olacoides Benth. In: Chemotaxonomie der pflanzen. Basel-Boston-Berlin: Birks4aUure Verlag; 1990. Band IX: 156-9.
201. Siqueira IR, Fochesatto C, da Silva AL, Nunes DS, Battastini AM, Netto CA, Elisabetsky E. Ptychopetalum olacoides, a traditional Amazonian "nerve tonic", posses anticholinesterase activity. Pharmacol Biochem Behav 2003;75(3):645-50.
202. da Silva AL, Bardini S, Nunes DS, Elisabetsky E. Anxiogenic properties of Ptychopetalum olacoides Benth. (Marapuama). Phytother Res 2002;16(3):223-6.
203. Tang W, Hioki H, Harada K, Kubo M, Fukuyama Y. Clerodane diterpenoids with NGF-potentiating activity from Ptychopetalum olacoides. J Nat Prod 2008;71(10):1760-3.
204. Gruenwald J, Brendeler T, Jaenicke C, Fileming T (Ed.). Pomegranate (Punica granatum). In: Physicians' desk reference (PDR) for herbal medicines. 2. ed. Montvale-New Jersey: Medical Economics Company; 2000. p. 605.
205. Council of the European Community. Council Directive 88/388/EEC of 22 June 1988 on the approssimation of the law of the Member States relating flavourings for use in foodstuffs and to source materials for their production. Official Journal of the European Communities L 184, 15/07/1988.
206. Food and Drug Administration, Centre for Food Safety and Applied Nutrition. Quassia amara. FDA Poison Plant Database; 2006.
207. Woo GH, Shibutani M, Inoue K, Fujimoto H, Takahashi M, Lee KY, Hirose M. Promoting potential of a Jamaica Quassia extract in a rat medium-term hepatocarcinogenesis biossay. Food Chem Toxicol 2007;45(7):1160-4.
208. Pandey MM, Rastogi S, Rawat AK. Saussurea costus: botanical, chemical and pharmacological review of an ayurvedic medicinal plant. J Ethnopharmacol 2007;110(3):379-90.
209. Yu HH, Lee JS, Lee KH, Kim KY, You YO. Saussurea lappa inhibits the growth, acid production, adhesion, and water-insoluble glucan synthesis of Streptococcus mutans. J Ethnopharmacol 2007;111(2):413-7.
210. Schumacher J, Cupp MJ. Scullcap. In: Cupp MJ (Ed). Toxicology and clinical pharmacology of herbal products. Totowa: Humana Press Inc; 2000. p. 215-21.
211. Wolfson P, Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med 2003;9(2):74-8.
212. Germany. Bundesinstitut für Arzeneimittel und Medizinprodukte. Kommission E. Salsaparillae radix (Sarsaparillewurzel) Monograph. Bundesanzeiger 1990; n. 164 on 01.09.1990.
213. Gruenwald J, Brendeler T, Jaenicke C, Fileming T (Ed.). Salsaparilla (Smilax spp). In: Physicians' desk reference (PDR) for herbal medicines. 2. ed. Montvale-New Jersey: Medical Economics Company; 2000. p. 661.
214. Willuhn G. Arnica montana L.: portrait of a medicinal plant. Pharm Ztg 1991;136(12):9-12, 14, 18, 21, 24-6.
215. Woerdenbag HJ, Merfort I, Passreiter CM, Schmidt TJ, Willuhn G, van Uden W, Pras N, Kampinga HH, Konings AW. Cytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC4 and the COLO 320 cell lines. Planta Med 1994;60(5):434-7.
216. American College of Toxicology. Sage (Ed.). Final report on the safety assessment of Arnica montana extract and Arnica montana. Int J Toxicol 2001;20(2):1-11.
217. Barnes J, Anderson LA, Phillipson JD. Herbal medicines: a guide for healthcare professionals. 2. ed. London and Chicago: Pharmaceutical Press; 2002.
218. Haller CA, Anderson IB, Kim SY, Blanc PD. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Adverse Drug React Toxicol Rev 2002;21(3):143-50.
219. Potti GR, Kurup PA. Antibacterial principle of the root bark of Calophyllum inophyllum: isolation and antibacterial activity. Indian J Exp Biol 1970;8(1):39-40.
220. Itoigawa M, Ito C, Tan HT, Kuchide M, Tokuda H, Nishino H, Furukawa H. Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum. Cancer Lett 2001;169(1):15-9.
221. Le Coz CJ. Allergic contact dermatitis from tamanu oil (Calophyllum inophyllum, Calophyllum tacamahaca). Contact Dermatitis 2004;51(4):216-7.
222. Yimdjo MC, Azebaze AG, Nkengfack AE, Meyer AM, Bodo B, Fomum ZT. Antimicrobial and cytotoxic agents from Calophyllum inophyllum. Phytochemistry 2004;65(20):2789-95.
223. Said T, Dutot M, Martin C, Beaudeux JL, Boucher C, Enee E, Baudouin C, Warnet JM, Rat P. Cytoprotective effect against UV-induced DNA damage and oxidative stress: role of new biological UV filter. Eur J Pharm Sci 2007;30(3-4): 203-10.
224. Blazek Z. Content and localization of furocoumarins in some types of the genus Heracleum. Cesk Farm 1969;18(6):250-7.
225. Brázdovicová B, Kostálová D, Strocinská E, Tomko J. Isolation and identification of oroselol and other furocoumarin derivatives from Heracleum sphondylium L. roots. Cesk Farm 1982;31(9):346-7.
226. Oakley AM, Ive FA, Harrison MA. String trimmer's dermatitis. J Soc Occup Med 1986;36(4):143-4.
227. Tirillini B, Ricci A. Furocoumarin production by callus tissues of Heracleum sphondylium L. Phytother Res 1998;12: S25-6.
228. Weimarck G, Nilsson E. Phototoxicity in Heracleum sphondylium. Planta Med 1980;38(2):97-111.
229. Cieśla L, Bogucka-Kocka A, Hajnos M, Petruczynik A, Waksmundzka-Hajnos M. Two-dimensional thin-layer chromatography with adsorbent gradient as a method of chromatographic fingerprinting of furanocoumarins for distinguishing selected varieties and forms of Heracleum spp. J Chromatogr A 2008;1207(1-2): 160-8.
230. Tattje DH, Bos R. Composition of essential oils of Ledum palustre. Planta Med 1981;41(3):303-7.
231. Germany. Bundesinstitut für Arzeneimittel und Medizinprodukte. Kommission E. Raphani sativi radix Monograph. Bundesanzeiger 1986. 177a.
232. Monografie sulle droghe vegetali. In: REFIT (Repertorio Fitoterapico) 2. ed. Milano: OEMF; 1996. p. 428-9.
233. Frohne D, Pfander HJ. Giftpflanzen: Ein Handbuch für Apotheker, Ärzte, Toxikologen und Biologen (Gebundene Ausgabe). Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1997.
234. Daschinamzhilov ZhB, Yatzenko TV, LyarsKaya LV, Aseeva TA, Nikolaev SM, Badluev OA, Sambueva ZG. Hepatoprotective effect of herbal medicine "dig-da-shitan" on liver damaged by ethanol. Rastitel'nye Resursy 2007;43(1):130-5.
235. Guan S, Lu J, Liu J. Protective effects of ursolic acid extract from Ledum palustre against genetic damage on mice. Aibian Jibian Tubian 2009;21(1):68-9.
236. Hammer KA, Carson CF, Riley TV, Nielsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 2006;44:616-25.
237. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE. Annual Report of the American Association of Poison. Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol 2007:46; 927-1057.
238. Fico G, Tome F. Alkaloids in Nigella damascena seeds. An hypotesis on their biological role. Eur J Pharm Sci 1998:6 (Supp. 1); S79.
239. Fico G, Panizzi L, Flamini G, Braca A, Morelli I, Tome F, Cioni PL. Biological screening of Nigella damascena for antimicrobial and molluscicidal activities. Phytother Res 2004;18:468-70.
240. Landa P, Marsik P, Havlik J, Kloucek P, Vanek T, Kokoska L. Evaluation of antimicrobial and anti-inflammatory activities of seed extracts from six Nigella species. J Med Food 2009;12:408-15.
241. Appendino G, Bianchi F, Bader A, Campagnuolo C, Fattorusso E, Taglialatela-Scafati O, Bianco-Molina M, Macho A, Fiebich BL, Bremner P, Heinrich M, Ballero M, Muñoz E. Coumarins from Opopanax chironium. New dihydrofuranocoumarins and differential induction of apoptosis by imperatorin and heraclenin. J Nat Prod 2004;67:532-6.
242. Goswami S, Gupta VK, Sharma A, Gupta BD. Supramolecular structure of S-(+)-marmesin - a linear dihydrofuranocoumarin. Bull Mater Sci 2005;28:725-9.
243. De Vincenzi M, Mancini E. Monographs on botanical flavouring substances used in foods. Part VI. Fitoterapia 1997;68:49-61.
244. Gruenwald J, Brendeler T, Jaenicke C, Fileming T (Ed.). Patchouli (Pogostemon cablin). In: Physicians' desk reference for herbal medicines. 2. ed. Montvale-New Jersey: Medical Economics Company; 2000. p. 575.
245. Zhu BC, Henderson G, Yu Y, Laine RA. Toxicity and repellency of patchouli oil and patchouli alcohol against Formosan submediterranean termites Coptotermes formosanus Shiraki (Isoptera: Rhinotermitidae). J Agric Food Chem 2003;51:4585-8.
246. Pavela R. Insecticidal properties of several essential oils on the house fly (Musca domestica L.). Phytoter Res 2008;22:274-8.
247. Casida JE. Pyrethrum flowers and pyrethroid insecticides. Environ Health Perspect 1980;34:189-202.
248. Pandita PN, Sharma SD. Pyrethrin content and dry-flower yield of some strains of dalmatian pyrethrum (Tanacetum cinerariifolium). Indian J Agric Sci 1990;60:693.
249. Wandahwa P, Van Ranst E, Van Damme P. Pyrethrum (Chrysanthemum cinerariaefolium Vis) cultivation in West Kenya: Origin, ecological conditions and management. Ind Crops Prod 1996;5:307-22.
250. Keskitalo M, Angers P, Earle E, Pehu E. Chemical and genetic characterization of calli derived from somatic hybridization between tansy (Tanacetum vulgare L.) and pyrethrum (Tanacetum cinerariifolium (Trevir.) Schultz-Bip.). Theor Appl Genet 1999;98:1335-43.
251. Savona G, Piozzi F, Bruno M, Dominguez G, Rodriguez B, Servettaz O. Teucretol, a neo-clerodane diterpenoid from Teucrium creticum. Phytochemistry 1987;26:3285-8.
252. Lahlou S, Tahraoui A, Israili Z, Lyoussi B. Diuretic activity of the aqueous extracts of Carum carvi and Tanacetum vulgare in normal rats. J Ethnopharmacol 2007;110:458-63.
253. Lahlou S, Tahraoui A, Israili Z, Lyoussi B. Acute and chronic toxicity of a lyophilised aqueous extract of Tanacetum vulgare leaves in rodents. J Ethnopharmacol 2008;117:221-7.